Africa has become indispensable to global health research. But indispensable is not the same as influential. The continent bears a significant share of the world’s infectious disease burden, provides rich biodiversity for natural-product discovery, contributes valuable epidemiological data, and hosts numerous clinical studies. Yet African scientists remain underrepresented in the earliest stages of drug discovery, where molecules are designed, intellectual property is generated, and scientific direction is established.
This imbalance is no longer inevitable.
Source: cen.acs.org



